Rilpivirine Tablet, Film Coated
Product Images NDC 42385-999

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rilpivirine (NDC 42385-999). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Laurus Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rilpivirine-figure1 (Rilpivirine Figure1)

Rilpivirine-figure1 (Rilpivirine Figure1)
A text panel listing various drug names and substances including carbamazepine, phenobarbital, rifampin, dexamethasone, esomeprazole, omeprazole, rabeprazole, oxcarbazepine, phenytoin, rifapentine, St. John's wort (Hypericum perforatum), lansoprazole, and pantoprazole. The list is shown as bullet points across two columns.*
FDA Label Image

Rilpivirine-figure2 (Rilpivirine Figure2)

Rilpivirine-figure2 (Rilpivirine Figure2)
A text panel listing possible symptoms or side effects including fever, tiredness, difficulty breathing or swallowing, skin blisters, swelling of the face, lips, mouth, tongue, or throat, general ill feeling, muscle or joint aches, blisters or mouth sores, and redness or swelling of the eyes (conjunctivitis).*
FDA Label Image

Rilpivirine-figure3 (Rilpivirine Figure3)

Rilpivirine-figure3 (Rilpivirine Figure3)
A portion of a drug facts or safety information panel listing possible side effects related to the medication, including yellowing of skin or eyes (jaundice), light colored stools, pain or tenderness in the right stomach area, loss of appetite, dark or tea colored urine, nausea, and vomiting.*
FDA Label Image

Rilpivirine-figure4.jpg (Rilpivirine Figure4)

Rilpivirine-figure4.jpg (Rilpivirine Figure4)
Rilpivirine Tablets 25 mg film-coated oral tablets label by Laurus Labs Limited. The label includes dosage information, storage instructions, manufacturer and labeler details including Laurus Generics Inc and Laurus Labs Limited, along with warnings about medicine interactions and substitution. The package size indicated is 30 tablets with Rx only status.*
FDA Label Image

Rilpivirine-structure (Rilpivirine Structure)

Rilpivirine-structure (Rilpivirine Structure)
Chemical structure of rilpivirine hydrochloride, showing its molecular arrangement including cyanide groups, aromatic rings, and nitrogen atoms as part of the compound's structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.